We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
28.00 | 9.33% | 328.00 | 325.50 | 330.00 | 350.00 | 303.00 | 304.00 | 1,285,192 | 16:35:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medicinal Chems,botanicl Pds | 139.99M | -45.16M | -0.4676 | -6.95 | 313.89M |
TIDMOXB
RNS Number : 8627P
Oxford Biomedica PLC
05 September 2017
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
1 Issuer Oxford BioMedica PLC ------ ------------------------ ------------------------------------ 2 Reason for notification Notification relates to DTR 3.1.2R ------ ------------------------ ------------------------------------ 3 Name of PDMR Martin Diggle ------ ------------------------ ------------------------------------ 4 Connected person Notification relates to following connected persons: Vulpes Testudo Fund ------ ------------------------ ------------------------------------ 5 Notification Notification in respect of in respect of holdings of persons in 4 above ------ ------------------------ ------------------------------------ 6 Description Oxford BioMedica PLC ordinary of shares shares of 1p each ------ ------------------------ ------------------------------------ 7 Name of registered Vulpes Life Sciences Fund shareholders - 549,932,000 shares and number of Vulpes Testudo Fund - 33,334,434 shares shares ------ ------------------------ ------------------------------------ 8 Nature of transaction Disposal ------ ------------------------ ------------------------------------ 9 Number of shares N/A acquired ------ ------------------------ ------------------------------------ 10 Percentage of N/A issued class acquired ------ ------------------------ ------------------------------------ 11 Shares disposed Vulpes Testudo Fund - 2,377,600 ------ ------------------------ ------------------------------------ 12 Percentage of Vulpes Testudo Fund - 0.08% issued class disposed ------ ------------------------ ------------------------------------ 13/14 Price per share Vulpes Testudo Fund of transactions, Sold 2,377,600 shares @ GBP0.1009, and date 31 Aug 2017 ------ ------------------------ ------------------------------------ 15 Total holding Vulpes Life Sciences Fund following notification - 549,932,000 shares and total percentage 17.7% holding following Vulpes Testudo Fund - 30,956,834 notification shares 1.0% ------ ------------------------ ------------------------------------ 16 Date issuer 05 Sept 2017 informed ------ ------------------------ ------------------------------------ 23 Any additional None information ------ ------------------------ ------------------------------------ 24 Contact name S. Paynter, Chief Financial and telephone Officer number Oxford BioMedica +44 (0)1865 783000 ------ ------------------------ ------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBGGDCBSGBGRU
(END) Dow Jones Newswires
September 05, 2017 06:45 ET (10:45 GMT)
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions